Plante Moran Financial Advisors, LLC Catalent, Inc. Transaction History

Plante Moran Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$87.2 - $114.05 $3,662 - $4,790	42 New	42 $5,000
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $3,202 - $4,232	-34 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$119.57 - $139.07 $4,065 - $4,728	34 New	34 $4,000
Q2 2018 Jul 26, 2018	SELL	$38.72 - $42.52 $1,006 - $1,105	-26 Closed	0 $0
Q1 2018 May 01, 2018	SELL	$39.4 - $47.39 $5,791 - $6,966	-147 Reduced 84.97%	26 $1,000
Q4 2017 Feb 01, 2018	BUY	$37.27 - $43.02 $6,447 - $7,442	173	173 $7,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.